Merck shares rose 2.46% in premarket trading

Tiger Newspress2021-10-04

Merck shares rose 2.46% in premarket trading.

Soon after the promising data disclosed by Merck for its COVID-19 pill, being developed in partnership with Ridgeback Biotherapeutics, countries, including the U.K. and Malaysia, have shown willingness to procure the experimental antiviral drug.

An effective, convenient oral COVID-19 treatment could generate over $10 billion of annual sales, Reuters reported citing estimates from Jefferies.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • JoelLee
    2021-10-07
    JoelLee
    Yayyyy
  • JoelLee
    2021-10-05
    JoelLee
    Reply and comment thx pls
  • TK360
    2021-10-05
    TK360
    Nice, saves lives
  • MHh
    2021-10-04
    MHh
    Hmm… prevention is better than cure 
  • HeroSmurf
    2021-10-04
    HeroSmurf
    Swee!!
  • BoonHuat
    2021-10-04
    BoonHuat
    Nice.
发表看法
19